Zoetis (ZTS) Construction in Progress (2012 - 2025)
Zoetis (ZTS) posted quarterly Construction in Progress of $1.3 billion for Q4 2025, down 4.29% year-over-year from $1.4 billion in Q4 2024, and down 4.29% quarter-over-quarter from $1.4 billion in Q4 2024.
Zoetis (ZTS) Construction in Progress (2012 - 2025) Analysis & Trends
Zoetis (ZTS) has reported Construction in Progress for 14 consecutive years, with $1.3 billion the latest figure, recorded in Q4 2025.
- In Q4 2025, Construction in Progress fell 4.29% year-over-year to $1.3 billion; the TTM figure through Dec 2025 stood at $1.3 billion (down 4.29% YoY), while the FY2025 annual figure was $1.3 billion, down 4.29% from the prior year.
- Construction in Progress slipped to $1.3 billion in Q4 2025 per ZTS's latest filing, from $1.4 billion in the prior quarter.
- Across five years, Construction in Progress topped out at $1.4 billion in Q4 2024 and bottomed at $742.0 million in Q4 2021.
- Historically, Construction in Progress has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2023.
- Annual changes were most pronounced in 2023 — Construction in Progress jumped 33.29% — and 2025, when it fell 4.29%.
- Zoetis' Construction in Progress stood at $742.0 million in 2021, then advanced by 9.7% to $814.0 million in 2022, then surged by 33.29% to $1.1 billion in 2023, then grew by 24.7% to $1.4 billion in 2024, then slipped by 4.29% to $1.3 billion in 2025.
- Business Quant data shows ZTS's Construction in Progress at $1.3 billion in Q4 2025, $1.4 billion in Q4 2024, and $1.1 billion in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.30 Bn |
| Dec 31, 2024 | 1.35 Bn |
| Dec 31, 2023 | 1.09 Bn |
| Dec 31, 2022 | 814.00 Mn |
| Dec 31, 2021 | 742.00 Mn |
| Dec 31, 2020 | 673.00 Mn |
| Dec 31, 2019 | 553.00 Mn |
| Dec 31, 2018 | 454.00 Mn |
| Dec 31, 2017 | 254.00 Mn |
| Dec 31, 2016 | 212.00 Mn |
| Dec 31, 2015 | 185.00 Mn |
| Dec 31, 2014 | 167.00 Mn |
| Dec 31, 2013 | 199.00 Mn |
| Dec 31, 2012 | 159.00 Mn |